Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

IHE ETF Forecast & Price Targets

Compare
See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

IHE Analyst Ratings

Moderate Buy
53ConsensusRatings
48Buy5Hold0Sell
Based on the Wall Street analyst consensus for 53 of IHE’s holdings.

IHE 12 Month Forecast

$126.62â–²(17.66% Upside)
Based on Wall Street analyst 12-month price targets for 53 of iShares U.S. Pharmaceuticals ETF’s holdings in the last 3 months. The average price target is $126.62 with a high forecast of $147.48 and a low forecast of $97.55. The average price target represents a 17.66% change from the last price of $107.61.
Highest Price Target$147.48Average Price Target$126.62Lowest Price Target$97.55

IHE Stocks With Highest Upside Potential

IHE highest upside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$2.75(690.23% Upside)
Moderate Buy$34.00(479.22% Upside)
Strong Buy$18.96(428.08% Upside)
Strong Buy$29.50(338.34% Upside)
Strong Buy$24.13(246.13% Upside)

IHE Stocks With Highest Downside Potential

IHE highest downside
NamePrice & ChangeAnalyst ConsensusAnalyst Price Target
Hold$22.17(-20.03% Downside)
Hold$34.79(-4.41% Downside)
Moderate Buy$29.62(-2.95% Downside)
Strong Buy$66.00(-1.76% Downside)
Moderate Buy$287.88(5.37% Upside)

IHE ETF FAQ

What is IHE’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 53 of IHE’s holdings, iShares U.S. Pharmaceuticals ETF’s 12-month average price target is $126.62.
What is IHE’s upside potential, based on the analysts’ average price target?
IHE’s average price target of $126.62 represents a 17.66% upside from its last price of $107.61.
Is IHE a Buy, Sell or Hold?
iShares U.S. Pharmaceuticals ETF has a consensus rating of Moderate Buy, based on the analyst consensus for 53 of IHE’s holdings: 48 rated Buy, 5 rated Hold and 0 rated Sell.
What is iShares U.S. Pharmaceuticals ETF’s price target?
The average price target for iShares U.S. Pharmaceuticals ETF is $126.62, based on Wall Street analyst 12-month price targets for 53 of IHE’s holdings, issued in the past 3 months. The highest price target is $147.48 and the lowest is $97.55. The average price target represents a 17.66% increase from the last price of $107.61.
What is IHE’s expense ratio?
IHE’s expense ratio is 0.37%.
How many holdings does IHE have?
IHE holds 54 assets.
How can I buy shares of IHE?
You can buy shares of IHE through a brokerage account. Compare brokers on our Best Online Brokers page.